ArticleJAMA network open2024

Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk.

Xavier Sendaydiego et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.